e-learning
resources
Madrid 2019
Monday, 30.09.2019
Involvement of the environment and inflammation in pulmonary remodelling
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Role of probiotics Bfidobacterium breve and Lactobacillus rhmanosus on lung inflammation and airway remodeling in an experimental model of chronic obstructive pulmonary disease.
F. Aimbire (São José dos Campos, Brazil), J. Carvalho (São José dos Campos, Brazil), A. Fialho (São José dos Campos, Brazil), M. Miranda (São José dos Campos, Brazil), R. Albertini (São José dos Campos, Brazil), A. Keller (São Paulo, Brazil)
Source:
International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Session:
Involvement of the environment and inflammation in pulmonary remodelling
Session type:
Thematic Poster
Number:
2452
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Aimbire (São José dos Campos, Brazil), J. Carvalho (São José dos Campos, Brazil), A. Fialho (São José dos Campos, Brazil), M. Miranda (São José dos Campos, Brazil), R. Albertini (São José dos Campos, Brazil), A. Keller (São Paulo, Brazil). Role of probiotics Bfidobacterium breve and Lactobacillus rhmanosus on lung inflammation and airway remodeling in an experimental model of chronic obstructive pulmonary disease.. 2452
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
The impact of anti-IgE treatment on the airway microbiome in asthma.
Occupational and drug-induced ILDs
Related content which might interest you:
Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease
Source: Eur Respir J , 49 (3) 1601328; DOI: 10.1183/13993003.01328-2016
Year: 2017
The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Bacterial load in chronic obstructive pulmonary disease and its relationship with airway inflammation and lung function
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011
Association between airway inflammation and systemic inflammation in stable chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006
Effect of 3-week pulmonary rehabilitation on airway inflammation in patients with chronic obstructive lung diseases
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007
Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?
Source: Eur Respir J 2002; 20: 9S-19S
Year: 2002
Pattern of airway inflammation and remodeling in mild chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Modulation of airway inflammation to prevent exacerbations of COPD
Source: Eur Respir Rev 2005; 14: 78-82
Year: 2005
Small airway inflammation in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 501s
Year: 2001
Stable chronic obstructive pulmonary disease-bronchial colonization and inflammatory response
Source: Eur Respir J 2001; 18: Suppl. 33, 105s
Year: 2001
PG6 Assessing and monitoring airway inflammation in asthma andÿchronic obstructive pulmonary disease
Source: Milan 2017 - Educational material
Year: 2017
Airway epithelial inflammatory responses and clinical parameters in COPD
Source: Eur Respir J 2003; 22: 94-99
Year: 2003
Variability and effects of bronchial colonization on symptoms and lung function in moderate COPD
Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients
Year: 2006
Endogenous hydrogen sulfide reduces airway hyperresponsiveness and airway inflammation in a rat model of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009
IL-17C associates with disease severity during acute exacerbation of chronic obstructive disease and promotes neutrophilic lung inflammation
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
LSC - 2019 - Resistive breathing aggravates pulmonary inflammation and emphysema in experimental models of chronic obstructive pulmonary disease
Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Year: 2019
Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 325-331
Year: 2002
Bacterial bronchopulmonary infection-induced exacerbation of chronic obstructive pulmonary diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 258s
Year: 2002
Systemic inflammation in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 5S-13S
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept